Sale of Solvay Pharmaceuticals, Inc. Coming; Could Fetch $6.66 Billion

Bookmark and Share

-Information memos on drugs business out in days -source

-Solvay stresses other options still open

LONDON, April 30 (Reuters) - Belgium's Solvay will send out information memorandums about its pharmaceutical business to potential buyers of the unit in the coming days, a source familiar with the matter said.

Back to news